• myGriffith
    • Staff portal
    • Contact Us⌄
      • Future student enquiries 1800 677 728
      • Current student enquiries 1800 154 055
      • International enquiries +61 7 3735 6425
      • General enquiries 07 3735 7111
      • Online enquiries
      • Staff phonebook
    View Item 
    •   Home
    • Griffith Research Online
    • Journal articles
    • View Item
    • Home
    • Griffith Research Online
    • Journal articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

  • All of Griffith Research Online
    • Communities & Collections
    • Authors
    • By Issue Date
    • Titles
  • This Collection
    • Authors
    • By Issue Date
    • Titles
  • Statistics

  • Most Popular Items
  • Statistics by Country
  • Most Popular Authors
  • Support

  • Contact us
  • FAQs
  • Admin login

  • Login
  • High-Throughput Screening in Natural Product Drug Discovery in Australia Utilising Australia's Biodiversity

    Author(s)
    Quinn, RJ
    Griffith University Author(s)
    Quinn, Ronald J.
    Year published
    1999
    Metadata
    Show full item record
    Abstract
    Novel Australian biodiversity is being examined as a potential source of new therapeutic agents. Drug discovery begins with attempts to find a molecule that causes a specific biological response, i.e., a “hit.” The trend in drug discovery is clearly towards rapid, high‐throughput screening (HTS) of large libraries of compounds. A particularly attractive option for HTS targets that has become available with the ability to clone human genes is to utilise human targets in the screening process. There is increased probability that the compounds discovered would be more effective in their eventual human target than may be the ...
    View more >
    Novel Australian biodiversity is being examined as a potential source of new therapeutic agents. Drug discovery begins with attempts to find a molecule that causes a specific biological response, i.e., a “hit.” The trend in drug discovery is clearly towards rapid, high‐throughput screening (HTS) of large libraries of compounds. A particularly attractive option for HTS targets that has become available with the ability to clone human genes is to utilise human targets in the screening process. There is increased probability that the compounds discovered would be more effective in their eventual human target than may be the case for compounds discovered using animal models or, indeed, animal gene products. HTS strategies involve screening of compound libraries, combinatorial libraries, and natural product extracts. The limiting factor in HTS is the ability to access large numbers of chemically diverse substances. Natural products are the greatest source of structural diversity. HTS of the unparalleled diversity in natural product extracts thereby offers one of the best chances for discovery of novel lead compounds and is complementary to the newly emerging source of compounds provided by combinatorial chemistry. However, the complexity of natural product extracts brings with it the added effort required to obtain a single pure compound.
    View less >
    Journal Title
    Drug Development Research
    Volume
    46
    Issue
    3-4
    DOI
    https://doi.org/10.1002/(SICI)1098-2299(199903/04)46:3/4<250::AID-DDR9>3.0.CO;2-8
    Subject
    Pharmacology and pharmaceutical sciences
    Publication URI
    http://hdl.handle.net/10072/173924
    Collection
    • Journal articles

    Footer

    Disclaimer

    • Privacy policy
    • Copyright matters
    • CRICOS Provider - 00233E
    • TEQSA: PRV12076

    Tagline

    • Gold Coast
    • Logan
    • Brisbane - Queensland, Australia
    First Peoples of Australia
    • Aboriginal
    • Torres Strait Islander